Drug recall · July 31, 2019
Clobazam Oral Suspension recall
Why: Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bionpharma Inc., 600 Alexander Road, Princeton, NJ 08540, NDC 69452-116-45.
- Lots / codes
Lot #: 18246, Exp 09/2020
- Quantity
- 3,020 bottles
- Company
- Bionpharma Inc., Princeton, NJ
- Distribution
- Nationwide in the USA
- Initiated
- July 16, 2019 · Voluntary: Firm initiated
- Classified
- July 25, 2019
- Reported
- July 31, 2019
- Ended
- March 5, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clobazam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.